Clearbridge Health Ltd. · SGX:1H3
Clearbridge Health — Q2 2020 Earnings Presentation
23 slides from Clearbridge Health's earnings presentation, Aug 26, 2020
Slide 1: Redefining Healthcare in Asia with Precision
REDEFINING HEALTHCARE IN ASIA WITH PRECISION EMPOWERING PATIENT CARE WITH CLARITY Corporate Presentation Q2 2020
Slide 2: Important Notice
Important Notice Clearbridge Health Limited (the “Company”) is a company listed on the Catalist Board of the Singapore Exchange Securities Trading Limited (the “SGX-ST”). This presentation has been prepared by the Company and has been reviewed by the Company’s sponsor, United Overseas Bank Limited (
Slide 3: Building the First Broad Based Precision Medicine Platform in Asia
Building the First Broad Based Precision Medicine Platform in Asia OUR APPROACH • Data-driven clinical initiatives • Collaborations with technologies providers relevant to Asia • Direct access to consumers via owned primary healthcare and specialists providers Strategic equity investments in medical
Slide 4: Our Value Creation Process
Our Value Creation Process • Capitalising valuation multiple differential between public and private market comparables Unlocking Value • Healthcare EV/EBITDA: 5.5x – 71.9x • P/ EBITDA of key potential targets range from 3x – 12x • Maximising revenue growth by achieving economies of scope (products
Slide 5: EBITDA-focused expansion strategy in Asia
EBITDA-focused expansion strategy in Asia Issue of convertible bonds Raised S$11.0m to fuel further expansion in the region Expansion of medical Conversion of S$2.7m of Secured new funds for CBBP clinic in Hong Kong convertible bonds IPO of Clearbridge Singapore & Indonesia (subsidiary) Conversion o
Slide 6: One of the First in Asia
One of the First in Asia - Shanghai Kaizhun, provision of overseas healthcare expertise and services - Clearbridge Medica Sdn Bhd, distribution network for diagnostic services - Clearbridge Medical Group (Hong Kong), a medical clinic in Causeway Bay caters to China medical tourists and domestic pati
Slide 7: Record Quarterly Adjusted EBITDAR of S$3.6 million in Q2-20
Record Quarterly Adjusted EBITDAR of S$3.6 million in Q2-20 Quarterly Revenue (S$'000) Adjusted EBITDAR(1) (S$’000) 16,000 4,500 14,136 14,000 3,500 9.5x adjusted EBITDAR growth 3,608 12,000 37.5x revenue growth 3,908 since inflection in Q3-19 since Q1-18 2,500 10,000 8,288 7,324 1,500 8,000 6,392 5
Slide 8: Net Debt/Equity Ratio Improved from 0.160 as of 31 March to 0.035 as of 30 June
Net Debt/Equity Ratio Improved from 0.160 as of 31 March to 0.035 as of 30 June S$’000 30 June 2020 31 March 2020 31 December 2019 Current borrowings 4,106 3,109 4,797 Non-current borrowings 14,439 16,641 16,850 Total borrowings 18,545 19,750 21,647 Cash at banks and short-term deposits 16,517 11,21
Slide 9: Q2-20 Business Update
Q2-20 Business Update 1. Distributorship for COVID-19 Antibody Test Kits • The Group has successfully secured a distributorship for COVID-19 antibody test kits in the Philippines, Indonesia, Myanmar and Vietnam. • However, due to the uncertainty relating to the response of healthcare regulators and
Slide 10: Merits of Clearbridge Health
Merits of Clearbridge Health 1. Direct proxy to the defensive and high-growth healthcare industry in Asia 2. Global trend of precision medicine underpins the industry’s strong prospects and market potential in Asia 3. Differentiated business strategy by building the first broad based precision medic
Slide 11: Indonesia: PT Indo Genesis Medika and PT Tirta Medika Jaya
“Rising healthcare focus and expenditure with Indonesia’s health coverage program introduced in 2014 for the entire population of more than 1. PT Indo Genesis Medika (IGM Labs) 260 million” • One of the largest clinical laboratories in Indonesia, co-operating 15 clinical laboratories and other patie
Slide 12: PT Indo Genesis Medika (IGM Labs)
PT Indo Genesis Medika (IGM Labs) • Recurring cash flow business • Services are reimbursed by Indonesia health coverage program • 5 to 7 years contract with revenue sharing of 55% to 70% to IGM Labs • Co-operating 15 clinical laboratories and other patient care facilities under joint operation contr
Slide 13: PT Indo Genesis Medika (IGM Labs)
PT Indo Genesis Medika (IGM Labs) RSUP. Dr. Mohammad Hoesin RS Cipto Mangunkusumo RS Umum Pusat Sanglah RS Umum Pusat H. Adam Malik RS Islam Jakarta Cempaka Putih Palembang Denpasar Bali Medan RS Jogja Internasional Hospital RSUD Kabupaten Badung RSUD Kota Surakarta RSUD Dr. Zainoel Abidin Banda RS
Slide 14: PT Tirta Medika Jaya (TMJ)
PT Tirta Medika Jaya (TMJ) RS Bhayangkara Sartika Asih – RSUD Dr Soehadi Projonegoro - Sragen RSUD Dr H Marsidi Judono - Belitung Bandung • Recurring cash flow business • Services are reimbursed by Indonesia health coverage program • 7 to 10 years contract with revenue sharing of 60% to 70% to TMJ •
Slide 15: Clearbridge Medical Group Philippines (CMP)
“In the Philippines, the doctor to patient ratio is 1:33,000, which is significantly 1. Clearbridge Medical Group Philippines (CMP) higher than the global • Four-storey multi-specialty medical center in Quezon City average of 1:6,600” • Improved facilities to offer comprehensive range of diagnostic
Slide 16: Clearbridge Medical Group Philippines
Clearbridge Medical Group Philippines • Four-storey multi-specialty medical centre in Quezon • Provision of COVID-19 testing related services on-site and off-site • Renal care center with 15 dialysis machines, running 2 shifts/day • In-house laboratory and pharmacy 16
Slide 17: Clearbridge Medical Group Philippines
Clearbridge Medical Group Philippines ClearSkin Advance Dermatology & Laser Centre ClearSMILE Dental Clinic Advanced Dental Care and Diagnostics • Quezon City, Metropolitian Manila • Offers wide array of dental treatments, including orthodontics, • Market thru social influencers dental implants and
Slide 18: Singapore: Medic Surgical & Laser Clinic and Dental Clinics
“Healthcare expenditure in Singapore is estimated to triple by 2030, rising to $44 billion from $17 billion in 2013. 1. Medic Surgical & Laser Clinic Personal healthcare expenditure will rise in tandem, and is projected to hit $28 billion in • Aesthetic and medical clinic located at Tanjong Pagar, 2
Slide 19: Medic Surgical & Laser Clinic
Medic Surgical & Laser Clinic • Services offered include skin trauma, wound management & scar improvement, LASER skin rejuvenation, skin smoothening & whitening 19
Slide 20: Dental Focus Group
Dental Focus Group Locations People’s Park Centre Bendemeer Changi Road Hougang Jurong West Yishun Ang Mo Kio Simei • Each clinic is equipped with 2-3 dental chairs and cone beam CT scan • Dental Focus is run by 14 dental surgeons 20
Slide 21: Clearbridge Medical Group (Hong Kong)
“More than 2 million women have crossed the border to be administered the HPV Gardasil 9, a vaccine guarding against cervical cancer.” 1. Clearbridge Medical Group (Hong Kong) • Medical clinic in Causeway Bay • Adherence to Singapore’s high standards enhances the clinic’s branding and upholds public
Slide 22: Clearbridge Medical Group Hong Kong
Clearbridge Medical Group Hong Kong • 1,500 sq. ft clinic receives visiting physicians and specialists to provide a wider range of medical and health screening services • Collaboration with insurance companies and healthcare partners to serve domestic patients and medical tourists • Adherence to Sin
Slide 23: Thank you
Thank you